Approach to a Mass of Unknown Significance Location Kinetics Systemic Manifestations.

Slides:



Advertisements
Similar presentations
© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare Inherited Pre-disposition.
Advertisements

Hereditary aspects of upper GI malignancy Eamonn Sheridan Consultant in Clinical Genetics.
Familial adenomatous polyposis
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk-Colorectal Cancer:
Update on Screening of Gastrointestinal Diseases Niraj Jani, M.D. Greater Baltimore Medical Center 1/30/15.
USPSTF Screening Recommendations: Implications for Adults at Higher Risk NYFAHC Roundtable, June 18, 2013 Robert A. Smith, PhD Senior Director, Cancer.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Colorectal Cancer Ramon Garza III, M.D.. Colorectal CA DNA Sequencing Mismatch Repair Genes Genomics Role of PCR and FISH in Colon CA.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
Genetics and Primary Care
Hereditary Colorectal Cancer: An Overview Felice Schnoll-Sussman,MD Jay Monahan Center for Gastrointestinal Health New York Hospital/ Weill Cornell Medical.
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Genetics of Colorectal Cancer
Lessons from Hereditary Colorectal Cancer
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
Introduction to Cancer Genetics and Genomics Apostolos Psychogios, MD, FACMG Associate Professor of Pediatrics LeeAnne Brown Chair of Clinical Excellence.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
DR Jameel Tariq Miro.  Lifetime incidence 5%  90% of cases occur after age 50  One-third of patients with colorectal cancer die from the disease 
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Colon cancer is the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development
Colorectal cancer in Norway Maria Mai Ingvild Hvalby.
Joint Hospital Surgical Grand Round 19 June 2004.
Colorectal cancer Khayal AlKhayal MD,FRCSC
Genetics & Colorectal Cancer
Cancer Genetics Genetic Disorder. What are cancer genetics? Many cancer-predisposing traits are inherited in an autosomal dominant fashion, that is, the.
Genetics of Colorectal Cancer
An Overview of Clinical Cancer Genetics
High risk population in GI field how we can find them? Ahmad Shavakhi MD Associate professor of gastroenterology.
Case Study Student Name: Nicole Yaun Date:11/8/2010.
Terminology of Neoplasms and Tumors  Neoplasm - new growth  Tumor - swelling or neoplasm  Leukemia - malignant disease of bone marrow  Hematoma -
Colorectal carcinoma Dr.Mohammadzadeh.
Familial Adenomatous Polyposis (FAP) Most common, 1:10,000 individuals Most common, 1:10,000 individuals Risk of CA of affected patients: 100% Risk.
The Effect of Celecoxib, a Cyclooxegenase-2 Inhibitor, In Familial Adenematous Polyposis Gideon Steinbach, M.D., Ph. D., Patrick Lynch, M.D., J.D., Robin.
Gardner’s syndrome – A case report 佛教慈濟綜合醫院大林分院 內科部胃腸肝膽科 曾國枝 2002/4/6.
SNDA : CELEBREX TM INDICATION Reduction and Regression of Adenomatous Colorectal Polyps in Familial Adenomatous Polyposis Patients FDA ODAC Presentation.
Colon Cancer. Epidemiology 3 rd most common cancer in males and females. Accounts for 11% of cancer deaths. In 2000, 130,200 cases (colon and rectum).
 FAP - familial adenomatous polyposis  germline mutations in the APC gene (“gatekeeper”)  HNPCC - hereditary nonpolyposis colon cancer (a.k.a. Lynch.
Familial Cancer. General Principles Mutations inherited through germ cells contribute to a minority of tumours Two hits usually needed germline/somatic.
Case Study. Patient: Pam Halpert Age: 24 years of age Gender: Female Height: 5’7” Weight: 150 lbs. Vital Signs: HR: 70 bpm Respiratory rate: 15 rpm Blood.
 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.
Amber Ellis and Russell Brown
Change in bowel habits … 60 year old male Complains of progressive constipation for the past 6 months.
BRCA1 and BRCA2 are genes which normally help to prevent breast cancer by making proteins which inhibit abnormal cellular growth. While a woman with an.
» LARGE INTESTINES ˃APPENDIX ˃ASCENDING COLON ˃TRANSVERSE COLON ˃DESCENDING COLON ˃SIGMOID.
HPI A 32 yo G2P2 woman presents to her PCP because of a lump that she felt on her lower belly. It is not painful but she thinks it has been growing in.
Cancer Genome Landscapes
NEOPLASIA CASES. CASE 1 A 20 year old female presented with a round mobile breast lump. She has no family history of breast cancer Question : What test.
LCC COL-1 See Pathologic Stage, Adjuvant Therapy, and Surveillance (LCC COL-3) Φ Φ Φ π π π Colon Cancer.
Identifying and Managing Hereditary Cancer Syndromes © 2005 Myriad Genetic Laboratories, Inc. Monica Trout, MS Genetic Counselor / Regional Medical Specialist.
Do you have 3 or more affected relatives? (2 or less)
Colorectal cancer Screening and Prevention Dr malek Alhamidi
A Prof Of Colorectal Surgery
HEREDITARY GASTROINTESTINAL CANCER SYNDROMES
Tumours of the large intestine
Cancer Can Not Comfort But Your Family Can
EPIDEMIOLOGY.
Irritable Bowel Syndrome
Cell Biology and Cancer
FAMILIAL ADENOMATOUS POLYPOSIS
Hereditary Colon Cancer Syndromes
James Roat, MD University of Cincinnati Division of Digestive Diseases
Colonic polyps and tumors
Presentation transcript:

Approach to a Mass of Unknown Significance Location Kinetics Systemic Manifestations

Differential Diagnosis of an Anterior Mediastinal Mass Thymoma Germ Cell Tumor/Teratoma Lymphoma

Shipp M et al. N Engl J Med 2005;352: Differential Diagnosis of an Anterior Mediastinal Mass

Malignancy Infection Granulomatous Disease Benign Tumors Others

Our Patient

Familial Adenomatous Polyposis (FAP) Autosomal Dominant Disease High penetrance (almost ~100) Mean age of onset ,000s of colonic polyps Average age of colon cancer is 39 Accounts for ~1% of all colorectal cancers

Genetics of FAP Classic FAP caused by mutation in APC gene Accounts for 90% of cases Discovered at Johns Hopkins by Kenneth Kinzler and Bert Vogelstein Genetic Test commercially available

FAP Unaffected

Management of FAP Surveillance with annual colonoscopies Colectomy is recommended when polyps are large, dysplastic or with villous histology Patients with small and/or sparse polyps can be followed and schedule colectomy after graduation from High School Total proctocolectomy with ileoanal pouch Subtotal colectomy with ileorectoal anastomsosis

Classic Metastatic Colon Cancer to Lung

MalignancyAbsolute Lifetime Risk (%) Colon100 Duodenum3.0–5.0 Thyroid2.0 Brain (Meduloblastoma)2.0 Ampullary1.7 Pancreas1.7 Hepatoblastoma1.6 Gastric0.6* Extracolonic Malignancies in FAP patients

DESMOID TUMORS Benign Slow Growing Tumors Develop in 10-15% of patients with FAP Typically intra-abdominal and arise at sites of trauma (ie Surgery) Composed of spindle cells and abundant fibrous stroma

Final Differential Diagnosis Atrial Myxoma Indolent Lymphoma Proliferative Fibrosing Mediastinitis

DIAGNOSIS Desmoid Tumor arising in site of Surgical trauma (CABG in 2002) in a patient with FAP